🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

FinnGen-tuloksia University of Oulu:n tutkijoilta: Tutkimuksessa havaittiin lukuisia välilevyjen rakenteeseen ja tulehdustekijöihin mahdollisesti vaikuttavia geenialueita sekä aiemmin tuntemattomia yhteyksiä hermostoon ja hermojen toimintaan liittyviin geeneihin. oulu.fi/fi/uutiset/tut…

New FinnGen-based findings from University of Oulu: Researchers discovered dozens of new genes associated with disc herniations, many of which relate to the nervous system and nerve function. The results from Johannes Kettunen's group were published in Nature Communications: nature.com/articles/s4146…

Uusi naisten tahattomaan lapsettomuuteen liittyvä geenivirhe tunnistettiin Suomessa FinnGen-aineiston avulla. Kyseinen TBPL2-geenivirhe vaikuttaa munasolujen kypsymiseen ja johtaa näin naisten hedelmättömyyteen, jos sen on perinyt molemmilta vanhemmilta: helsinki.fi/fi/uutiset/gee…

Are you passionate about software development and eager to make a meaningful impact in healthcare? Join our team at FinnGen, one of the largest genetics research projects globally! Location: Helsinki, Finland FIMM HelsinkiUni University of Helsinki Apply by 16 Dec here⬇️: jobs.helsinki.fi/job-invite/365…

1/6 🚨 Thrilled to share our new preprint on the genetics of dermatophytosis susceptibility on medRxiv! 🚨 With over 250K cases and 1.37M controls across 4 cohorts, we uncover 30 loci that affect risk for this fungal infection affecting 20% of the global population. 🌍

We are delighted to welcome Bayer AG as our newest pharmaceutical industry partner! Their expertise in the Nordic healthcare ecosystem and commitment to advancing pharmaceutical R&D in Finland will further strengthen FinnGen’s scientific mission. Read more: finngen.fi/en/finngen-wel…

FinnGen team wishes you a peaceful holiday season! As we reflect on the progress made this year, we are grateful to every participant and collaborator who has contributed to our genetic research journey. We look forward to making more exciting discoveries together in 2025!

Tänään pääsimme kertomaan FinnGenin edistymisestä ja lähitulevaisuuden suunnitelmista yrityspartneriemme paikallisille edustajille. Lämmin kiitos kaikille mukaan päässeille hyvästä keskustelusta!

Looking for weekend reading? I’m excited to share latest work from the group, a tour de force effort by the fantastic graduate student Yu Fu on the impact of chrX and dosage compensation on complex traits: biorxiv.org/content/10.110…

Sex chromosome trisomies - including 47,XXY, 47,XYY, and 47,XXX - are the most common type of chromosome abnormalities in humans. Yet, our understanding of the prevalence and associated health outcomes is primarily driven by observational studies of clinically diagnosed